OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 18, 2016
The agency says the increasing requests for orphan drug designation has resulted in a change in FDA’s review goals.
July 11, 2016
FDA reviewers have found that Sandoz's GP2015, a biosimilar version of Amgen's Enbrel, is highly similar to the original product in terms of purity, safety, and potency.
July 08, 2016
A Federal Circuit court ruled biosimilar makers must wait 180 days after receiving FDA approval before bringing drugs to market.
July 07, 2016
The assay will provide information on biosimilar comparability.
July 06, 2016
Novo Nordisk broke ground on an expanded production plant for insulin in Kalundborg, Denmark.
Teligent is expanding its manufacturing and R&D complex in New Jersey.
July 02, 2016
Integrating quality and compliance with technology transfer and careful project management are key in starting up a facility and launching a biologic drug.
Early planning for the integration of clean-in-place systems for equipment cleaning is key.
Aseptic spray drying provides an alternative to lyophilization as an enabling stabilization technology for parenteral biologic formulations.
July 01, 2016
A study by MilliporeSigma and the Economist Intelligence Unit reviews growth drivers and approaches to mitigate risk.